AnalysisNews

AXGN today

$55.73+$0.33 (+0.60%)close Nov 13, 2026

Trend

DailyDowntrend (confirmed)

4 hourStrong Bullish

1 hourStrong Bullish

15 minBearish

5 minSymmetric Triangle

Daily trend turns up above $37.40

Key levels

Resistance$56.40

Support$52.74

Support$47.57

Latest news & SEC filings

ProductAxogen Shares Initial Results for Prostate Nerve Repair Work

SEC FilingAxogen, Inc. filed a report on a major company event (Form 8-K)

All AXGN news →

About Axogen

Axogen makes and sells medical implants for repairing and regenerating peripheral nerves. Its offerings include Avance nerve allografts, Axoguard nerve connectors, protectors, and caps, plus Avive+ Soft Tissue Matrix. Surgeons apply these implants to treat nerve damage caused by injuries and operations. The company serves customers across North America and Europe.

Based on the company's 10-K filed Feb 24, 2026.

Nasdaq · Healthcare

Axogen, Inc. (AXGN)

$55.73+0.33 (+0.60%)
WATCHLISTGrade: BRisk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
39.4244.2249.0353.8355.73Oct 13Oct 21Oct 29Nov 6
High57.45
Low55.01
Open55.88
Volume665K
Avg Vol1.78M
VWAP56.39
30d High58.63
30d Low34.62
30d Chg+49.73%

What Is the Price Target for AXGN?

SEPT Low Target

$45.05

SEPT Mid Target

$53.00

SEPT High Target

$60.95

Analyst Consensus

$53.00

Current: $56.78Upside: -6.7%Confidence: 85%Method: Analyst Consensus

Is AXGN a Buy or Sell Right Now?

56
Investability Score
WATCHLIST12-18 months

Thesis

  • •Revenue growing 20.2% YoY with ACCELERATING trend — accelerating momentum.
  • •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment rising.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for AXGN.

Start Free Trial →

Is AXGN Overvalued or Undervalued?

Valuation Verdict

OVERVALUED

Methods Used

P/E Forward, P/B, Analyst Consensus

Fair Value

$38.78

42

Moat Score

NARROW

5/9

Piotroski Score

10.6

Altman Z-Score

What Is Smart Money Doing with AXGN?

Insider Signal

SELLING

0 buys / 8 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

DISTRIBUTING

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

AXGN Growth Story

Revenue YoY

20.2%

3yr Revenue CAGR

17.6%

EPS Growth YoY

-47.83%

FCF Growth YoY

-304.5%

Revenue Trend

ACCELERATING

Dark Pool Trades for AXGN

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for AXGN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
19:23:49$55.661,000$$56KMIDPOINT
19:01:51$56.261,000$$56KSELL
18:27:17$56.512,203$$124KSELL
17:57:36$56.511,450$$82KSELL
17:52:12$56.551,000$$57KBUY

5 dark pool trades shown · $$375K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Options Flow for AXGN

PREVIEW

SEPT Investing provides real-time options flow tracking for AXGN, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.

TypeStrikeExpiryDTEPremiumSizeTrade
CALL$35Nov 207$$24.2K11SWEEP
CALL$35Nov 207$$22001SWEEP
CALL$35Nov 207$$52.8K24SWEEP
CALL$35Nov 207$$22001SWEEP
CALL$35Nov 207$$22001SWEEP

5 options trades shown · 100% calls

Unusual activity, GEX levels, max pain, and dealer positioning

See full options flow

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Axogen, Inc. (AXGN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (8 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

AXGN — frequently asked questions

What is AXGN stock price today?

Axogen, Inc. (AXGN) is at $55.73, up 0.60% (+$0.33) at the Nov 13, 2026 close.

Why is AXGN stock moving today?

Latest AXGN news — Nov 9, 2026: Axogen Shares Initial Results for Prostate Nerve Repair Work · Nov 9, 2026: Axogen, Inc. filed a report on a major company event (Form 8-K)

What is the AXGN price target?

The average analyst price target for AXGN is $53.00, ranging from $48 to $55, based on 9 analysts. Latest: Barclays maintains on Oct 23, 2026.

What do analysts rate AXGN?

Analyst ratings for AXGN: 2 Buy, 10 Hold, 0 Sell — consensus Hold.

Did AXGN beat earnings?

AXGN last reported on Oct 28, 2026: EPS $0.21 vs $0.13 expected — a beat of 59.9%.

Does AXGN pay a dividend?

AXGN does not currently pay a dividend.

What are AXGN support and resistance levels?

Support: $52.74, $47.57, $43.98. Resistance: $56.40.

What are insiders doing with AXGN?

Insider activity: SELLING, 0 buys and 8 sells in the last 90 days.

What is the latest news on AXGN?

Nov 9, 2026: Axogen Shares Initial Results for Prostate Nerve Repair Work · Nov 9, 2026: Axogen, Inc. filed a report on a major company event (Form 8-K)